Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study. (Record no. 22333054)

MARC details
000 -LEADER
fixed length control field 02116 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516124239.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201304s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1537-6613
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/infdis/jis750
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Eron, Joseph J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130404
245 00 - TITLE STATEMENT
Title Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Journal of infectious diseases
Date of publication, distribution, etc. Mar 2013
300 ## - PHYSICAL DESCRIPTION
Extent 740-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-HIV Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiretroviral Therapy, Highly Active
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Viral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV Infections
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV-1
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heterocyclic Compounds, 3-Ring
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxazines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pilot Projects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Plasma
General subdivision virology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridones
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrrolidinones
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element RNA, Viral
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Raltegravir Potassium
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viral Load
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clotet, Bonaventura
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Durant, Jacques
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Katlama, Christine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kumar, Princy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lazzarin, Adriano
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Poizot-Martin, Isabelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Richmond, Gary
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Soriano, Vincent
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ait-Khaled, Mounir
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fujiwara, Tamio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Jenny
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Min, Sherene
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vavro, Cindy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yeo, Jane
773 0# - HOST ITEM ENTRY
Title The Journal of infectious diseases
Related parts vol. 207
-- no. 5
-- p. 740-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/infdis/jis750">https://doi.org/10.1093/infdis/jis750</a>
Public note Available from publisher's website

No items available.